New Mexico’s full Senate has given approval to legislation that would legalize medical psilocybin.
Dried psilocybin mushrooms.
The New Mexico Senate voted 33 to 4 today to approve Senate Bill 219, the Medical Psilocybin Act, moving the measure to the House for consideration. The legislation had previously cleared the Senate Finance Committee on Monday, following earlier approvals by the Senate Judiciary Committee and the Senate Tax, Business and Transportation Committee.
If enacted, the bill would allow individuals with certain behavioral health conditions—including major treatment-resistant depression, PTSD, substance use disorders, and end-of-life care—to receive psilocybin-assisted treatment. It would also establish an advisory board, a treatment equity fund, and a research fund, while removing psilocybin from the state’s Controlled Substances Act to protect patients, clinicians, and producers.
The program would be implemented by Dec. 31, 2027.
“When we’re facing epidemic levels of depression, anxiety, PTSD, and other debilitating mental health conditions, we owe it to those suffering to explore promising new treatments like psilocybin,” said State Representative Elizabeth Thomson (D), who is sponsoring a companion bill in the House. “By establishing a highly regulated, state-run program, we can provide alternative options to those not responding to traditional treatment, in a safe, controlled environment.”
